Placental arsenic concentrations in relation to both maternal and infant biomarkers of exposure in a US cohort

Journal of Exposure Science and Environmental Epidemiology

Volumn 25, Issue 6, 2015, Pages 599-603

  Punshon, Tracy ^a   Davis, Matthew A ^b   Marsit, Carmen J ^c   Theiler, Shaleen K ^d   Baker, Emily R ^d   Jackson, Brian P ^d   Conway, David C ^d   Karagas, Margaret R ^d  

^a Lamont Doherty Earth Observatory   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^d New Hampshire Dartmouth Psychiatric Research Center   (United States)

Author keywords

Arsenic; biomarker; low level; placenta

Indexed keywords

ARSENIC; BIOLOGICAL MARKER; DRINKING WATER;

ADULT; ANALYSIS; CHEMISTRY; ENVIRONMENTAL EXPOSURE; EPIDEMIOLOGY; FEMALE; HUMAN; INFANT; MALE; NAIL; NEW HAMPSHIRE; PLACENTA; PREGNANCY; URINE;

ADULT; ARSENIC; BIOMARKERS; DRINKING WATER; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; INFANT; MALE; NAILS; NEW HAMPSHIRE; PLACENTA; PREGNANCY;

EID: 84944513599     PISSN: 15590631     EISSN: 1559064X     Source Type: Journal    
DOI: 10.1038/jes.2015.16     Document Type: Article

References (33)

1. Zosky GR. In utero exposure to low dose arsenic via drinking water impairs early life lung mechanics in mice. BMC Pharmacol Toxicol 2013; 14: 13.
2. Rahman M, Sohel N, Yunus M, Chowdhury ME, Hore SK, Zaman K et al. Increased childhood mortality and arsenic in drinking water in Matlab, Bangladesh: a population-based cohort study. PLoS One 2013; 8: e55014.
3. Farzan SF, Karagas MR, Chen Y. In utero and early life arsenic exposure in relation to long-term health and disease. Toxicol Appl Pharmacol 2013; 272: 384-390.
4. Waalkes MP, Liu J, Germolec DR, Trempus CS, Cannon RE, Tokar EJ et al. Arsenic exposure in utero exacerbates skin cancer response in adulthood with contemporaneous distortion of tumor stem cell dynamics. Cancer Res 2008; 68: 8278-8285.
5. Esteban-Vasallo MD, Aragones N, Pollan M, Lopez-Abente G, Perez-Gomez B. Mercury, cadmium, and lead levels in human placenta: a systematic review. Environ Health Perspect 2012; 120: 1369-1377.
6. Waalkes MP, Liu J. Early-life arsenic exposure: methylation capacity and beyond. Environ Health Perspect 2008; 116: 104.
7. Liaw J, Marshall G, Yuan Y, Ferreccio C, Steinmaus C, Smith AH. Increased childhood liver cancer mortality and arsenic in drinking water in northern Chile. Cancer Epidemiol Biomarkers Prev 2008; 17: 1982-1987.
8. Bodwell JE, Gosse JA, Nomikos AP, Hamilton JW. Arsenic disruption of steroid receptor gene activation: complex dose-response effects are shared by several steroid receptors. Chem Res Toxicol 2006; 19: 1619-1629.
9. Milton AH, Shahidullah SM, Smith W, Hossain KS, Hasan Z, Ahmed KT. Association between chronic arsenic exposure and nutritional status among the women of child bearing age: a case-control study in Bangladesh. Int J Environ Res Public Health 2010; 7: 2811-2821.
10. Gamble MV, Liu X, Slavkovich V, Pilsner JR, Ilievski V, Factor-Litvak P et al. Folic acid supplementation lowers blood arsenic. Am J Clin Nutr 2007; 86: 1202-1209.
11. Gamble MV, Liu XH, Ahsan H, Pilsner JR, Ilievski V, Slavkovich V et al. Folate and arsenic metabolism: a double-blind, placebo-controlled folic acid-supplementation trial in Bangladesh. Am J Clin Nutr 2006; 84: 1093-1101.
12. Fei DL, Koestler DC, Li Z, Giambelli C, Sanchez-Mejias A, Gosse JA et al. Association between In Utero arsenic exposure, placental gene expression, and infant birth weight: a US birth cohort study. Environ Health 2013; 12: 58.
13. Karp WB, Robertson AF. Correlation of human placental enzymatic activity with trace metal concentration in placentas from three geographical locations. Environ Res 1977; 13: 470-477.
14. Baglan RJ, Brill AB, Schulert A, Wilson D, Larsen K, Dyer N et al. Utility of placental tissue as an indicator of trace element exposure to adult and fetus. Environ Res 1974; 8: 64-70.
15. Iyengar GV, Rapp A. Human placenta as a 'dual' biomarker for monitoring fetal and maternal environment with special reference to potentially toxic trace elements. Part 1. Physiology, function and sampling of placenta for elemental characterization. Sci Total Environ 2001; 280: 195-206.
16. Concha G, Vogler G, Lezcano D, Nermell B, Vahter M. Exposure to inorganic arsenic metabolites during early human development. Toxicol Sci 1998; 44: 185-190.
17. Cottingham KL, Karimi R, Gruber JF, Zens MS, Sayarath V et al. Diet and toenail arsenic concentrations in a New Hampshire population with arseniccontaining water. Nutr J 2013; 12: 149-159.
18. Davis MA, Li Z, Gilbert-Diamond D, Mackenzie TA, Cottingham KL, Jackson BP et al. Infant toenails as a biomarker of in utero arsenic exposure. J Expo Sci Environ Epidemiol 2014; 24: 467-473.
19. Davis MA, Mackenzie TA, Cottingham KL, Gilbert-Diamond D, Punshon T, Karagas MR. Rice consumption and urinary arsenic concentrations in US children. Environ Health Perpect 2012; 120: 1418-1424.
20. Gilbert-Diamond D, Cottingham KL, Gruber JF, Punshon T, Sayarath V, Gandolfi AJ et al. Rice consumption raises a health concern: evidence from U.S. pregnant women. Proc Natl Acad Sci USA 2011; 108: 20656-20660.
21. Karagas MR, Le CX, Morris S, Blum J, Lu X, Spate V et al. Markers of low level arsenic exposure for evaluating human cancer risks in a US population. Int J Occup Med Environ Health 2001; 14: 171-175.
22. Karagas MR, Morris JS, Weiss JE, Spate V, Baskett C, Greenberg ER. Toenail samples as an indicator of drinking water arsenic exposure. Cancer Epidemiol Biomarkers Prev 1996; 5: 849-852.
23. Amaya E, Gil F, Freire C, Olmedo P, Fernandez-Rodriguez M, Fernandez MF et al. Placental concentrations of heavy metals in a mother-child cohort. Environ Res 2013; 120: 63-70.
24. Jin L, Zhang L, Li Z, Liu JM, Ye R, Ren A. Placental concentrations of mercury, lead, cadmium, and arsenic and the risk of neural tube defects in a Chinese population. Reprod Toxicol 2013; 35: 25-31.
25. Kippler M, Hoque AM, Raqib R, Ohrvik H, Ekstrom EC, Vahter M. Accumulation of cadmium in human placenta interacts with the transport of micronutrients to the fetus. Toxicol Lett 2010; 192: 162-168.
26. Leino O, Kiviranta H, Karjalainen AK, Kronberg-Kippila C, Sinkko H, Larsen EH et al. Pollutant concentrations in placenta. Food Chem Toxicol 2013; 54: 59-69.
27. Llanos MN, Ronco AM. Fetal growth restriction is related to placental levels of cadmium lead and arsenic but not with antioxidant activities. Reprod Toxicol 2009; 27: 88-92.
28. Tabacova S, Baird DD, Balabaeva L, Lolova D, Petrov I. Placental arsenic and cadmium in relation to lipid peroxides and glutathione levels in maternal-infant pairs from a copper smelter area. Placenta 1994; 15: 873-881.
29. Zadorozhnaja TD, Little RE, Miller RK, Mendel NA, Taylor RJ et al. Concentrations of arsenic, cadmium, copper, lead, mercuy and zinc in human placentas from two cities in Ukraine. J Toxicol Environ Health A 2000; 61: 255-263.
30. Iyengar GV, Rapp A. Human placenta as a 'dual' biomarker for monitoring fetal and maternal environment with special reference to potentially toxic trace elements. Part 3. Toxic trace elements in placenta and placenta as a biomarker for these elements. Sci Total Environ 2001; 280: 221-238.
31. Seaborg B, Bodurtha J. Nail size in normal infants. Establishing standards for healthy term infants. Clin Pediatr 1989; 28: 142-145.
32. Ayotte JD, Belaval M, Olson SA, Burow KR, Flanagan SM, Hinkle SR et al. Factors affecting temporal variability of arsenic in groundwater used for drinking water supply in the United States. Sci Total Environ 2014; 505: 1370-1379.
33. Karagas MR, Tosteson TD, Blum J, Klaue B, Weiss JE, Stannard V et al. Measurement of low levels of arsenic exposure: A comparison of water and toenail concentrations. Am J Epidemiol 2000; 152: 84-90.